Benefit-risk assessment of long-acting beta2-agonists in asthma.

Benefit-risk assessment of long-acting beta2-agonists in asthma.

Item
http://www.wikidata.org/entity/Q35683221
Limited beta2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmaticsPharmacogenomics of long-acting β2-agonists.New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.Chronic treatment in vivo with β-adrenoceptor agonists induces dysfunction of airway β(2) -adrenoceptors and exacerbates lung inflammation in mice.Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterolBeta-arrestins specifically constrain beta2-adrenergic receptor signaling and function in airway smooth muscleThe safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot studyRecent development in pharmacogenomics: from candidate genes to genome-wide association studies.Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.Safety of long-acting beta2-agonists in the treatment of asthma.Prescription patterns in asthma patients initiating salmeterol in UK general practice: a retrospective cohort study using the General Practice Research Database (GPRD).Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
P2860

Benefit-risk assessment of long-acting beta2-agonists in asthma.

Item
http://www.wikidata.org/entity/Q35683221
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@ast
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@en
type
label
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@ast
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@en
prefLabel
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@ast
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Benefit-risk assessment of long-acting beta2-agonists in asthma.
@en
P2093
P2888
P304
P31
P356
10.2165/00002018-200427040-00003
P433
P478
P577
P6179
P698
P921